Cost effectiveness of testing strategies for chronic hepatitis C

American Journal of Gastroenterology

Volumn 100, Issue 3, 2005, Pages 607-615

  Chapko, Michael K ^a   Sloan, Kevin L ^a   Davison, John W ^a   Dufour, D Robert ^a   Bankson, Daniel D ^a   Rigsby, Michael ^a   Dominitz, Jason A ^a  

^a VA Puget Sound Hlth Care S ^*

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; COMPUTER PROGRAM; COST EFFECTIVENESS ANALYSIS; DECISION THEORY; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; HEPATITIS C; HEPATITIS C VIRUS; IMMUNOBLOTTING; OPTICAL DENSITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIREMIA;

COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; FALSE POSITIVE REACTIONS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOENZYME TECHNIQUES; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIREMIA;

EID: 16844378070     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.40531.x     Document Type: Article

References (31)

1. Alter M, Kruszon-Moran D, Nainan O, et al. The prevalence of Hepatitis C virus infection in the United States 1988 through 1994. N Engl J Med 1999;341:556-62.
2. Seeff L, Miller R, Rabkin C, et al. 45-year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med 2000;132:105-ll.
3. Gretch D. Diagnostic tests for Hepatitis C. Hepatology 1997;26(suppl 1):43S-47S.
4. Alter MJ, Kuhnert WI, Finelli L. Guidelines for laboratory testing and result reporting of antibody to Hepatitis C virus. Morb Mortal Wkly Rep 2003;52:1-15.
5. Dufour D, Talastas M, Fernandez M, et al. Low-positive anti-hepatitis C virus enzyme immunoassay results: An important predictor of low likelihood of Hepatitis C infection. Clin Chem 2003;49:479-86.
6. Dufour D, Lott J, Nolte F, et al. Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clin Chem 2000;46:2027-49.
7. Carithers R, Marquardt A, Gretch D. Diagnostic testing for Hepatitis C. Semin Liv Dis 2000;30:159-70.
8. Younossi Z, McHutchison J. Serological tests for HCV infection. Viral Hepat Rev 1996;2:161-73.
9. Schiff E, De Medina M, Kahn R. New perspectives in the diagnosis of Hepatitis C. Semin Liv Dis 1999;19(suppl 1):3-15.
10. Pawlotsky J, Lonjon I, Hezode C, et al. What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? Hepatology 1998;27:1700-3.
11. Dhumeaux D, Doffoel M, Galmiche J. A French consensus conference on Hepatitis C: Screening and treatment. J Hepatol 1997;27:941-4.
12. National Institutes of Health. Management of Hepatitis C. NIH Consensus Statements 19, 1-44. 6-12-2002.
13. Department of Veterans Affairs Under Secretary for Health. Diagnostic Testing for Hepatitis C Virus. Under Secretary for Health's Information Letter IL.
14. Kaur S, Rybicki L, Bacon B, et al. Performance characteristics and results of a large-scale screening program for viral hepatitis and risk factors associated with exposure to viral Hepatitis B and C: Results of the National Hepatitis Screening Survey. Hepatology 1996;24:879-86.
15. Cheung R. Epidemiology of hepatitis C virus infection in American veterans. Am J Gastroenterol 2000;95:740-7.
16. Reindollar R. Hepatitis C and the correctional population. Am J Med 1999;107:100S-103S.
17. Flamm S, Parker R, Chopra S. Risk factors associated with chronic Hepatitis C virus infection: Limited frequency of an unidentified source of transmission. Am J Gastroenterol 1998;93:597-600.
18. College of American Pathologists AABB/CAP Viral Markers Survey 2004.
19. Andreu J, Abad M, Sanchez-Quijano A, et al. High rate of nonspecific anti-hepatitis C reactivity amongst homosexual men in comparison with that found in other sexually active groups active groups and blood donors. J Intern Med 1994;236:73-7.
20. Damen M, Cuypers H, Zaaijer H, et al. International collabor ative study on the second EUROHEP HCV-RNA reference panel. J Virol Meth 1996;58:175-85.
21. Vrielink H, Reesink H, van den Berg P, et al. Performance of three generations of Anti-Hepatitis C virus enzyme-linked immunosorbent assays in donors and patients. Transfusion 1997;37:845-9.
22. Davis G. Hepatitis C. In:Schiff E, Sorrell M, Maddrey W, eds. Schiffs diseases of the liver. Philadelphia: Lippencott-Raven, 1999:793-830.
23. Huber K, Sebesta C, Bauer K. Detection of common Hepatitis C virus subtypes with a third-generation enzyme immunoassay. Hepatology 1996;24:471-3.
24. Pawlotsky J, Bastie A, Pellet C, et al. Significance of indeterminate third-generation Hepatitis C virus recombinant immunoblot assay. J Clin Microbiol 1996;34:80-3.
25. dos Santos V, Azevedo R, Camargo M, et al. Serodiagnosis of hepatitis C virus. Am J Clin Pathol 1999;112:418-24.
26. Uyttendaele S, Claeys H, Mertens W, et al. Evaluation of third-generation screening and confirmatory assays for HCV antibodies. Vox Sang 1994;66:129.
27. Damen M, Zaaijer H, Cuypers H, et al. Reliability of the third-generation recombinant immunoblot assay for Hepatitis C. Transfusion 1995;35:745-9.
28. Zeuzem S, Ruster B, Roth W. Clinical evaluation of a new polymerase chain reaction assay (Amplicor HCV) for detection of Hepatitis C virus. Gastroenterology 1994;32:342-7.
29. U.S. Preventive Services task Force. Screening for hepatitis C virus infection in adults: Recommendation statement. Ann Intern Med 2004;140:462-4.
30. Chou R, Clark EC, Helfand M. Screening for hepatitis C virus infection: A review of the evidence for the U. S. Preventive Services Task Force. Ann Intern Med 2004;140:465-79.
31. Pawlotsky J. Use and interpretation of virologic tests. NIH Consensus Development Conference on Management of Hepatitis C: 2002, Bethesda, MD, pp. 39-42.